Join session

🇬🇧 Decentralization and Digitalization of Clinical Trials: a Key to the Future?

Nov 22, 2023 — 03:45 pm CET - 4:10 PM CET

Presented by

Françoise Lethiec

Johnson & Johnson Innovative Medicine

Research & Development Director

French National Committee for Research...

Deputy Director

Alexandre Guenoun

Global Client Service Partner and...

Presented by

Loic Chabanier

Global Client Service Partner and Europe West HS&W consulting Market Segment Leader

Alexandre Guenoun

Founder & CEO

Anne Le Louarn

Deputy Director

Françoise Lethiec

Research & Development Director

In partnership with

Suggested sessions

9:00 am - 9:25 am

🇬🇧 AI for Health 6th edition kick start

Managing partner and global industry lead for healthcare

Delphine Aguiléra-Caron

Johnson & Johnson Innovative Medicine France

Managing Director

9:25 am - 9:50 am

🇬🇧 Virtual cohort, but real recognition by payers?

Raphaelle Parker

Johnson & Johnson Innovative Medicine

Principal Scientist

Pr Stéphanie Allassonnière

Paris Cité University

Chair PR[AI]RIE & Professor

Pr Raphaël Porcher

Professor of Biostatistics

Yann-Mael Le Douarin

French Ministry of Health & Prevention

Medical Advisor e-Health

Dr Jean-Louis Fraysse

9:30 am - 9:50 am

Corporate Masterclass Stage

🇫🇷 Accès au marché DM embarquant de l’IA en santé mentale : quelques questions à se poser ?

Vincent Vercamer

French Ministry of Health & Prevention

Project Director – Market Access expert, Digital Health Delegation

French Ministry of Health & Prevention

Director of Digital Health Challenges for "Mental health" and "Aging well", Digital Health Delegation

9:30 am - 9:40 am

Startups Masterclass Stage

🇬🇧 Oncogenomics + AI :Transcriptomics signatures to allow prognosis and targeted therapy in...

Jean-Baptiste JAUSSAUD